Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.87 USD | -0.51% | +8.30% | -3.29% |
Financials (USD)
Sales 2024 * | 2.6B | Sales 2025 * | 2.73B | Capitalization | 1.81B |
---|---|---|---|---|---|
Net income 2024 * | 14M | Net income 2025 * | 22M | EV / Sales 2024 * | 1.58 x |
Net Debt 2024 * | 2.29B | Net Debt 2025 * | 2.07B | EV / Sales 2025 * | 1.42 x |
P/E ratio 2024 * |
117
x | P/E ratio 2025 * |
65.2
x | Employees | 7,850 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.94% |
Latest transcript on Amneal Pharmaceuticals, Inc.
1 day | -0.51% | ||
1 week | +8.30% | ||
Current month | -3.14% | ||
1 month | +0.34% | ||
3 months | +6.92% | ||
6 months | +53.26% | ||
Current year | -3.29% |
Managers | Title | Age | Since |
---|---|---|---|
Chirag K. Patel
FOU | Founder | 57 | 01-12-31 |
Chintu Patel
FOU | Founder | 53 | 01-12-31 |
Director of Finance/CFO | 57 | Nov. 06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ted Nark
BRD | Director/Board Member | 66 | Nov. 06 |
J. Buchi
BRD | Director/Board Member | 69 | Nov. 06 |
Paul Meister
CHM | Chairman | 71 | Nov. 06 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 5.87 | -0.51% | 959,058 |
24-04-25 | 5.9 | -2.48% | 3,428,210 |
24-04-24 | 6.05 | +12.04% | 3,066,491 |
24-04-23 | 5.4 | +0.56% | 1,382,090 |
24-04-22 | 5.37 | -0.92% | 1,847,588 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.29% | 1.81B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- AMRX Stock